Literature DB >> 34050758

GEPIA2021: integrating multiple deconvolution-based analysis into GEPIA.

Chenwei Li1,2, Zefang Tang3, Wenjie Zhang4, Zhaochen Ye4, Fenglin Liu4.   

Abstract

In 2017, we released GEPIA (Gene Expression Profiling Interactive Analysis) webserver to facilitate the widely used analyses based on the bulk gene expression datasets in the TCGA and the GTEx projects, providing the biologists and clinicians with a handy tool to perform comprehensive and complex data mining tasks. Recently, the deconvolution tools have led to revolutionary trends to resolve bulk RNA datasets at cell type-level resolution, interrogating the characteristics of different cell types in cancer and controlled cohorts became an important strategy to investigate the biological questions. Thus, we present GEPIA2021, a standalone extension of GEPIA, allowing users to perform multiple interactive analysis based on the deconvolution results, including cell type-level proportion comparison, correlation analysis, differential expression, and survival analysis. With GEPIA2021, experimental biologists could easily explore the large TCGA and GTEx datasets and validate their hypotheses in an enhanced resolution. GEPIA2021 is publicly accessible at http://gepia2021.cancer-pku.cn/.
© The Author(s) 2021. Published by Oxford University Press on behalf of Nucleic Acids Research.

Entities:  

Mesh:

Year:  2021        PMID: 34050758      PMCID: PMC8262695          DOI: 10.1093/nar/gkab418

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  12 in total

1.  Long noncoding RNA FEZF1-AS1 indicates a poor prognosis of gastric cancer and promotes tumorigenesis via activation of Wnt signaling pathway.

Authors:  Xiaoli Wu; Peichen Zhang; Hua Zhu; Shi Li; Xiangjian Chen; Lingyan Shi
Journal:  Biomed Pharmacother       Date:  2017-11-24       Impact factor: 6.529

2.  The Cancer Genome Atlas Pan-Cancer analysis project.

Authors:  John N Weinstein; Eric A Collisson; Gordon B Mills; Kenna R Mills Shaw; Brad A Ozenberger; Kyle Ellrott; Ilya Shmulevich; Chris Sander; Joshua M Stuart
Journal:  Nat Genet       Date:  2013-10       Impact factor: 38.330

3.  Robust enumeration of cell subsets from tissue expression profiles.

Authors:  Aaron M Newman; Chih Long Liu; Michael R Green; Andrew J Gentles; Weiguo Feng; Yue Xu; Chuong D Hoang; Maximilian Diehn; Ash A Alizadeh
Journal:  Nat Methods       Date:  2015-03-30       Impact factor: 28.547

4.  Simultaneous enumeration of cancer and immune cell types from bulk tumor gene expression data.

Authors:  Julien Racle; Kaat de Jonge; Petra Baumgaertner; Daniel E Speiser; David Gfeller
Journal:  Elife       Date:  2017-11-13       Impact factor: 8.140

5.  GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses.

Authors:  Zefang Tang; Chenwei Li; Boxi Kang; Ge Gao; Cheng Li; Zemin Zhang
Journal:  Nucleic Acids Res       Date:  2017-07-03       Impact factor: 16.971

6.  TIMER2.0 for analysis of tumor-infiltrating immune cells.

Authors:  Taiwen Li; Jingxin Fu; Zexian Zeng; David Cohen; Jing Li; Qianming Chen; Bo Li; X Shirley Liu
Journal:  Nucleic Acids Res       Date:  2020-07-02       Impact factor: 16.971

7.  Molecular and pharmacological modulators of the tumor immune contexture revealed by deconvolution of RNA-seq data.

Authors:  Francesca Finotello; Clemens Mayer; Christina Plattner; Gerhard Laschober; Dietmar Rieder; Hubert Hackl; Anne Krogsdam; Zuzana Loncova; Wilfried Posch; Doris Wilflingseder; Sieghart Sopper; Marieke Ijsselsteijn; Thomas P Brouwer; Douglas Johnson; Yaomin Xu; Yu Wang; Melinda E Sanders; Monica V Estrada; Paula Ericsson-Gonzalez; Pornpimol Charoentong; Justin Balko; Noel Filipe da Cunha Carvalho de Miranda; Zlatko Trajanoski
Journal:  Genome Med       Date:  2019-05-24       Impact factor: 15.266

8.  LAYN Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric and Colon Cancers.

Authors:  Jing-Hua Pan; Hong Zhou; Laura Cooper; Jin-Lian Huang; Sheng-Bin Zhu; Xiao-Xu Zhao; Hui Ding; Yun-Long Pan; Lijun Rong
Journal:  Front Immunol       Date:  2019-01-29       Impact factor: 7.561

9.  Comprehensive evaluation of transcriptome-based cell-type quantification methods for immuno-oncology.

Authors:  Gregor Sturm; Francesca Finotello; Florent Petitprez; Jitao David Zhang; Jan Baumbach; Wolf H Fridman; Markus List; Tatsiana Aneichyk
Journal:  Bioinformatics       Date:  2019-07-15       Impact factor: 6.931

Review 10.  Organ-protective effect of angiotensin-converting enzyme 2 and its effect on the prognosis of COVID-19.

Authors:  Hao Cheng; Yan Wang; Gui-Qiang Wang
Journal:  J Med Virol       Date:  2020-04-05       Impact factor: 2.327

View more
  62 in total

1.  FN1 encoding fibronectin as a pivotal signaling gene for therapeutic intervention against pancreatic cancer.

Authors:  Gayathri Ashok; Sravan Kumar Miryala; Megha Treesa Saju; Anand Anbarasu; Sudha Ramaiah
Journal:  Mol Genet Genomics       Date:  2022-08-18       Impact factor: 2.980

2.  Cuproptosis-related gene SLC31A1 is a potential predictor for diagnosis, prognosis and therapeutic response of breast cancer.

Authors:  Xiao Li; Zhaosheng Ma; Linhang Mei
Journal:  Am J Cancer Res       Date:  2022-08-15       Impact factor: 5.942

3.  [P4HA2 promotes occurrence and progression of liver cancer by regulating the PI3K/Akt/mTOR signaling pathway].

Authors:  L Shang; W Jiang; J Zhang; W Wu
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2022-05-20

4.  Expression of GOT2 Is Epigenetically Regulated by DNA Methylation and Correlates with Immune Infiltrates in Clear-Cell Renal Cell Carcinoma.

Authors:  Wallax Augusto Silva Ferreira; Edivaldo Herculano Correa de Oliveira
Journal:  Curr Issues Mol Biol       Date:  2022-05-25       Impact factor: 2.976

Review 5.  The Biological and Molecular Function of LINC00665 in Human Cancers.

Authors:  Cheng Zhang; Shu-Ning Xu; Ke Li; Jing-Hong Chen; Qun Li; Ying Liu
Journal:  Front Oncol       Date:  2022-05-19       Impact factor: 5.738

6.  CD206+ tumor-associated macrophages cross-present tumor antigen and drive antitumor immunity.

Authors:  Madhura Modak; Ann-Kathrin Mattes; Daniela Reiss; Wioletta Skronska-Wasek; Rebecca Langlois; Nicolas Sabarth; Renate Konopitzky; Fidel Ramirez; Katharina Lehr; Tobias Mayr; David Kind; Coralie Viollet; Lee Kim Swee; Jutta Petschenka; Karim C El Kasmi; Elfriede Noessner; Kerstin Kitt; Stefan Pflanz
Journal:  JCI Insight       Date:  2022-06-08

7.  Downregulated Copper Homeostasis-Related Gene FOXO1 as a Novel Indicator for the Prognosis and Immune Response of Breast Cancer.

Authors:  Rong Zeng; Bi Peng; Emin Peng
Journal:  J Immunol Res       Date:  2022-06-28       Impact factor: 4.493

8.  Sperm Autoantigenic Protein 17 Predicts the Prognosis and the Immunotherapy Response of Cancers: A Pan-Cancer Analysis.

Authors:  Zewei Tu; Jie Peng; Xiaoyan Long; Jingying Li; Lei Wu; Kai Huang; Xingen Zhu
Journal:  Front Immunol       Date:  2022-05-03       Impact factor: 8.786

9.  Landscape and Clinical Significance of Immune Checkpoint in Cutaneous Melanoma.

Authors:  Rui Mao; Fan Yang; Tongtong Zhang; Ji Li
Journal:  Front Immunol       Date:  2021-12-24       Impact factor: 7.561

10.  ITGB2 as a prognostic indicator and a predictive marker for immunotherapy in gliomas.

Authors:  Houshi Xu; Anke Zhang; Xiaying Han; Yanning Li; Zeyu Zhang; Liying Song; Wei Wang; Meiqing Lou
Journal:  Cancer Immunol Immunother       Date:  2021-07-27       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.